Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference

Thursday, June 5, 2008 General News
Email Print This Page Comment
Font : A-A+

IRVINE, Calif., June 4 Edwards LifesciencesCorporation (NYSE: EW), a world leader in products and technologies to treatadvanced cardiovascular disease, is scheduled to participate in the GoldmanSachs 29th Annual Global Healthcare Conference at the Ritz-Carlton LagunaNiguel Hotel in Dana Point, California on Wednesday, June 11, 2008.

Thomas M. Abate, Edwards Lifesciences' corporate vice president, chieffinancial officer & treasurer, is scheduled to speak to conference attendeesat 4:00 p.m. PT. A live webcast of the presentation will be available to allinterested parties on the Edwards Lifesciences investor relations website athttp://www.edwards.com/InvestorRelations/EventCalendar.htm. An archivedversion of the webcast will be available later that day on the Edwardsinvestor relations website in the News and Events section.

About Edwards Lifesciences

Edwards Lifesciences is the global leader in the science of heart valvesand hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards treatsadvanced cardiovascular disease with its market-leading heart valve therapies,and critical care and vascular technologies. In 2008, Edwards celebrates50 years of partnering with clinicians to develop life-saving innovations.The company's global brands, which are sold in approximately 100 countries,include CardioVations, the CardioVations logo, Carpentier-Edwards,Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additionalcompany information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. EdwardsLifesciences, the stylized E logo, CardioVations, the CardioVations logo,Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna andSwan-Ganz are trademarks of Edwards Lifesciences Corporation and areregistered in the United States Patent and Trademark Office.

SOURCE Edwards Lifesciences Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook